Press Releases

ROCKVILLE, Md. and BEIJING, March 16, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the year ended December 31, 2019, and

SOUTH SAN FRANCISCO, Calif., March 16, 2020 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology therapeutics, today reported its financial results for the year ended

In the news release, ADVISORY: Online Media Briefing About Acute Respiratory Distress Syndrome and COVID-19 Set for Monday with ARDS Foundation and Dr. Michael Matthay, issued 13-Mar-2020 by ARDS Foundation over PR Newswire, we are advised by the company that the webinar information in paragraph 1 has been updated. Attendees can register for the webinar by visiting:

CAMBRIDGE, Mass., March 16, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the fourth quarter and year ended December 31, 2019.Leap Highlights:Entered into an exclu

CAMBRIDGE, Mass., March 16, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced updated results from the Phase 2 PIONEER trial of avapritinib in patients with indolent systemic mastocytosis (SM) showing significant clinical im

RENO, Nev., March 16, 2020 /PRNewswire/ -- Rapid Dx for Life praises the leadership of the United States government by enacting a National Emergency for Covid19 on March 13th to enhance the resources and tools by which US states can effectively screen, treat, and cure this disease. All citi

HIGHLANDS RANCH, Colo., March 16, 2020 /PRNewswire/ -- Destination Pet today announced plans to acquire VitalPet. A formal written order approving the sale has been filed in the U.S. Bankruptcy Court in Houston. The transaction is expected to close in the coming weeks, subject to customary closing conditions.Headquartere

CARMIEL, Israel, March 16, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, announced today th

INDIANAPOLIS, March 16, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to baricitinib for the treatment of alopecia areata (AA), an autoimmune disorder that can cause unpredictable hair loss on the scalp, face a

WASHINGTON, March 16, 2020 /PRNewswire/ -- Every day, kids surprise their families by getting into medicine. There are more than 47,000 children under age 6 seen in emergency rooms every year for medicine poisoning – that's 5 children every hour. A new research report from Safe Kids Worldwide reveals common misconceptions families have about how to protect childre